{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:10:54Z","timestamp":1789546254447,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81900127"],"award-info":[{"award-number":["81900127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Science","award":["2020-RW310-002"],"award-info":[{"award-number":["2020-RW310-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00277-022-04968-8","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T18:02:51Z","timestamp":1665511371000},"page":"2611-2616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study"],"prefix":"10.1007","volume":"101","author":[{"given":"Wenrui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"1","key":"4968_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12185-008-0117-0","volume":"88","author":"JW Lee","year":"2008","unstructured":"Lee JW (2008) Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea. Int J Hematol 88(1):16\u201323. https:\/\/doi.org\/10.1007\/s12185-008-0117-0","journal-title":"Int J Hematol"},{"issue":"10","key":"4968_CR2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3324\/haematol.2018.193128","volume":"103","author":"X Jin","year":"2018","unstructured":"Jin X, He X, Cao X, Xu P, Xing Y, Sui S, Wang L, Meng J, Lu W, Cui R, Ni H, Zhao M (2018) Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice. Haematologica 103(10):1627\u20131634. https:\/\/doi.org\/10.3324\/haematol.2018.193128","journal-title":"Haematologica"},{"issue":"2","key":"4968_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187\u2013207. https:\/\/doi.org\/10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"issue":"17","key":"4968_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS (2018) Aplastic Anemia. N Engl J Med 379(17):1643\u20131656. https:\/\/doi.org\/10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"issue":"14","key":"4968_CR5","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1182\/blood-2010-01-261289","volume":"116","author":"JW Lee","year":"2010","unstructured":"Lee JW, Yoon SS, Shen ZX, Ganser A, Hsu HC, Habr D, Domokos G, Roubert B, Porter JB (2010) Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood 116(14):2448\u20132454. https:\/\/doi.org\/10.1182\/blood-2010-01-261289","journal-title":"Blood"},{"issue":"7","key":"4968_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3324\/haematol.2012.077669","volume":"98","author":"JW Lee","year":"2013","unstructured":"Lee JW, Yoon SS, Shen ZX, Ganser A, Hsu HC, El-Ali A, Habr D, Martin N, Porter JB (2013) Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study. Haematologica 98(7):1045\u20131048. https:\/\/doi.org\/10.3324\/haematol.2012.077669","journal-title":"Haematologica"},{"issue":"8","key":"4968_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3109\/08880018.2011.615050","volume":"28","author":"JW Lee","year":"2011","unstructured":"Lee JW, Jang PS, Chung NG, Cho B, Jeong DC, Kim HK (2011) Iron chelation therapy with deferasirox results in recovery of hematopoiesis in a child with aplastic anemia. Pediatr Hematol Oncol 28(8):718\u2013720. https:\/\/doi.org\/10.3109\/08880018.2011.615050","journal-title":"Pediatr Hematol Oncol"},{"issue":"13","key":"4968_CR8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s40265-021-01575-1","volume":"81","author":"YY Syed","year":"2021","unstructured":"Syed YY (2021) Hetrombopag: first approval. Drugs 81(13):1581\u20131585. https:\/\/doi.org\/10.1007\/s40265-021-01575-1","journal-title":"Drugs"},{"issue":"11","key":"4968_CR9","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1111\/jcmm.13809","volume":"22","author":"C Xie","year":"2018","unstructured":"Xie C, Zhao H, Bao X, Fu H, Lou L (2018) Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist. J Cell Mol Med 22(11):5367\u20135377. https:\/\/doi.org\/10.1111\/jcmm.13809","journal-title":"J Cell Mol Med"},{"key":"4968_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s40064-015-1446-0","volume":"4","author":"T Chen","year":"2015","unstructured":"Chen T, Chen Z, Zhang S, Zhang K, Wang L (2015) Development and validation of a LC-MS\/MS method for quantification of hetrombopag for pharmacokinetics study. Springerplus 4:652. https:\/\/doi.org\/10.1186\/s40064-015-1446-0","journal-title":"Springerplus"},{"issue":"16","key":"4968_CR11","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS (2017) Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 376(16):1540\u20131550. https:\/\/doi.org\/10.1056\/NEJMoa1613878","journal-title":"N Engl J Med"},{"issue":"1","key":"4968_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R Peffault de Latour","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, S\u00e1nchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Soci\u00e9 G, Mufti GJ, Dufour C, Risitano AM (2022) Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med 386(1):11\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"issue":"1","key":"4968_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/asheducation-2018.1.450","volume":"2018","author":"P Scheinberg","year":"2018","unstructured":"Scheinberg P (2018) Activity of eltrombopag in severe aplastic anemia. Hematology Am Soc Hematol Educ Program 2018(1):450\u2013456. https:\/\/doi.org\/10.1182\/asheducation-2018.1.450","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"4968_CR14","doi-asserted-by":"publisher","first-page":"e29066","DOI":"10.1002\/pbc.29066","volume":"68","author":"H Lesmana","year":"2021","unstructured":"Lesmana H, Jacobs T, Boals M, Gray N, Lewis S, Ding J, Kang G, Hale M, Weiss M, Reiss U, Wang W, Wlodarski M (2021) Eltrombopag in children with severe aplastic anemia. Pediatr Blood Cancer 68(8):e29066. https:\/\/doi.org\/10.1002\/pbc.29066","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4968_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1200931","volume":"367","author":"MJ Olnes","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367(1):11\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1200931","journal-title":"N Engl J Med"},{"issue":"1","key":"4968_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.2021012130","volume":"139","author":"BA Patel","year":"2022","unstructured":"Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, Quinones Raffo D, Wu CO, Young NS (2022) Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood 139(1):34\u201343. https:\/\/doi.org\/10.1182\/blood.2021012130","journal-title":"Blood"},{"issue":"24","key":"4968_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1182\/blood.2019000478","volume":"133","author":"T Winkler","year":"2019","unstructured":"Winkler T, Fan X, Cooper J, Desmond R, Young DJ, Townsley DM, Scheinberg P, Grasmeder S, Larochelle A, Desierto M, Valdez J, Lotter J, Wu C, Shalhoub RN, Calvo KR, Young NS, Dunbar CE (2019) Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag. Blood 133(24):2575\u20132585. https:\/\/doi.org\/10.1182\/blood.2019000478","journal-title":"Blood"},{"issue":"3","key":"4968_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/bjh.17232","volume":"192","author":"EM Groarke","year":"2021","unstructured":"Groarke EM, Patel BA, Gutierrez-Rodrigues F, Rios O, Lotter J, Baldoni D, St Pierre A, Shalhoub R, Wu CO, Townsley DM, Young NS (2021) Eltrombopag added to immunosuppression for children with treatment-na\u00efve severe aplastic anaemia. Br J Haematol 192(3):605\u2013614. https:\/\/doi.org\/10.1111\/bjh.17232","journal-title":"Br J Haematol"},{"issue":"6","key":"4968_CR19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00277-019-03652-8","volume":"98","author":"M Ecsedi","year":"2019","unstructured":"Ecsedi M, Lengline \u00c9, Knol-Bout C, Bosman P, Eikema DJ, Afanasyev B, Maschan A, Dreger P, Halkes CJM, Drexler B, Cortelezzi A, Dr\u00e9nou B, Patriarca A, Bruno B, Onofrillo D, Lanino E, Pulanic D, Serventi-Seiwerth R, Garnier A, Ljungman P, Bonifazi F, Giammarco S, Tournilhac O, Pioltelli P, Rov\u00f3 A, Risitano AM, de Latour RP, Dufour C, Passweg J (2019) Use of eltrombopag in aplastic anemia in Europe. Ann Hematol 98(6):1341\u20131350. https:\/\/doi.org\/10.1007\/s00277-019-03652-8","journal-title":"Ann Hematol"},{"key":"4968_CR20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006716","author":"O Goronkova","year":"2022","unstructured":"Goronkova O, Novichkova G, Salimova T, Kalinina I, Baidildina D, Petrova UN, Antonova K, Sadovskaya M, Suntsova E, Evseev DA, Matveev V, Venyov D, Khachatryan L, Litvinov D, Pshonkin A, Ovsyannikova G, Kotskaya N, Gobadze D, Olshanskaya Y, Popov A, Raykina E, Mironenko O, Voronin K, Purbueva B, Boichenko E, Dinikina Y, Guseynova E, Sherstnev D, Kalinina E, Mezentsev S, Streneva O, Yudina N, Plaksina O, Erega E, Maschan M, Maschan A (2022) Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2021006716","journal-title":"Blood Adv"},{"issue":"17","key":"4968_CR21","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","volume":"130","author":"E Vlachodimitropoulou","year":"2017","unstructured":"Vlachodimitropoulou E, Chen YL, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J (2017) Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator. Blood 130(17):1923\u20131933. https:\/\/doi.org\/10.1182\/blood-2016-10-740241","journal-title":"Blood"},{"issue":"9","key":"4968_CR22","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.1002\/ajh.25550","volume":"94","author":"B Fattizzo","year":"2019","unstructured":"Fattizzo B, Cavallaro F, Milesi G, Barcellini W (2019) Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag. Am J Hematol 94(9):E237-e239. https:\/\/doi.org\/10.1002\/ajh.25550","journal-title":"Am J Hematol"},{"key":"4968_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26543","author":"DJ Young","year":"2022","unstructured":"Young DJ, Fan X, Groarke EM, Patel B, Desmond R, Winkler T, Larochelle A, Calvo KR, Young NS, Dunbar CE (2022) Long-term eltrombopag for bone marrow failure depletes iron. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.26543","journal-title":"Am J Hematol"},{"key":"4968_CR24","doi-asserted-by":"publisher","first-page":"204062072210851","DOI":"10.1177\/20406207221085197","volume":"13","author":"G Peng","year":"2022","unstructured":"Peng G, He G, Chang H, Gao S, Liu X, Chen T, Li P, Han B, Miao M, Ge Z, Ge X, Li F, Li Y, Wang S, Wang Y, Shen Y, Zhang T, Zou J, Zhang F (2022) A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy. Ther Adv Hematol 13:20406207221085196. https:\/\/doi.org\/10.1177\/20406207221085197","journal-title":"Ther Adv Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04968-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04968-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04968-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T08:09:59Z","timestamp":1667981399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04968-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4968"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04968-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"10 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Blood Diseases Hospital, CAMS, and PUMC. All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008. Patients provided written informed consent for data exploitation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}